Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1655
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18360766 | LIQUID DISPENSING SYSTEM, COMPONENTS AND FEATURES THEREOF, AND METHODS OF USE THEREOF | Non-Final OA | The Procter & Gamble Company |
| 18262406 | SPIDER MITE REPELLENT | Non-Final OA | RIKEN |
| 18262344 | TOPICAL HUMAN MILK FORMULATIONS | Non-Final OA | PROLACTA BIOSCIENCE, INC. |
| 17828627 | METHOD FOR IMPROVING DIGESTIVE HEALTH | Final Rejection | Sanford Burnham Prebys Medical Discovery Institute |
| 18576170 | PROCESS FOR THE PREPARATION OF A PULMONARY SURFACTANT | Non-Final OA | CHIESI FARMACEUTICI S.P.A. |
| 18608731 | EXTRACTS ENRICHED WITH POLYPHENOLIC COMPOUNDS AND RELATED METHODS | Final Rejection | ATLAS365 INCORPORATED |
| 17948007 | COMPOSITION COMPRISING MITOCHONDRIA AND USE THEREOF FOR REPAIRING CARTILAGE DAMAGE OR IMPROVING OSTEOARTHRITIS | Final Rejection | TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD. |
| 18532215 | COMPOSITIONS | Non-Final OA | Provexis Natural Products Limited |
| 18488736 | CANNABIS OIL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF | Final Rejection | Constance Therapeutics, Inc. |
| 18286095 | Aristotelia chilensis EXTRACTS FOR TREATING FUNGAL INFECTIONS | Non-Final OA | Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerziteta E Beolgrade |
| 18281782 | PROCESS FOR PREPARING ABSOLUTES | Non-Final OA | INTERNATIONAL FLAVORS & FRAGRANCES INC. |
| 18374301 | FOOD SUPPLEMENT | Non-Final OA | MICROPHYT |
| 18282890 | THERAPEUTIC LENSES FOR USE AS OCULAR BANDAGE AND SIMULTANEOUSLY FOR THE ADMINISTRATION OF EYE DROPS | Non-Final OA | EYE PHARMA SPA |
| 17806014 | COMPOSITIONS AND METHODS FOR TREATING COVID-19 AND SYMPTOMS THEREOF | Non-Final OA | YUVA BIOSCIENCES, INC. |
| 18363793 | COMPOSITIONS AND METHODS COMPRISING HEMP EXTRACT FOR THE TREATMENT OF ANIMALS IN NEED | Non-Final OA | Portland Technology Holdings LLC |
| 18262653 | COMPOSITION COMPRISING COFFEE, COFFEE EXTRACT, AND BYPRODUCT AS ACTIVE INGREDIENT FOR PREVENTION OF CANCER METASTASIS OR FOR ALLEVIATION OR TREATMENT OF CANCER | Final Rejection | DAEJEON UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION |
| 18260956 | MODIFIED RELEASE FORMULATION COMPRISING WITHANOLIDES | Final Rejection | NUTRIVENTIA PRIVATE LIMITED |
| 18219723 | FEED ADDITIVE, LAYING HEN FEED, AND METHOD FOR PRODUCING ASTAXANTHIN EGGS | Non-Final OA | Algae Origin Inc. |
| 18207448 | ACTIVE PHARMACEUTICAL INGREDIENT | Non-Final OA | DAMIT HOLDINGS (PTY) LTD |
| 18039690 | SPECIFIC PATHOGEN FREE FEED COMPOSITION | Final Rejection | Chemovator GmbH |
| 17928952 | COMPOSITION CONTAINING CANNABINOIDS | Non-Final OA | HEALTHCANN SPÓLKA AKCYJNA |
| 17919373 | MEDICAL DEVICE COMPRISING AN ACELLULAR BIOLOGICAL MATRIX AND AT LEAST ONE POLYMER | Final Rejection | PH TECH |
| 17920725 | APPLICATION OF RADIX GENTIANAE MACROPHYLLAE AND MONOMER COMPOUND THEREOF IN KILLING MITES | Non-Final OA | GUANGZHOU MEDICAL UNIVERSITY PROPERTY OPERATION LIMITED CORPORATION |
| 17920734 | USE OF DANDELION AND ISOLATED COMPOUNDS THEREOF FOR KILLING MITES | Non-Final OA | GUANGZHOU MEDICAL UNIVERSITY PROPERTY OPERATION LIMITED CORPORATION |
| 17911920 | COMPOSITION FOR ENHANCING UROLITHIN PRODUCTION IN A HUMAN SUBJECT | Final Rejection | Migalis ApS |
| 17905646 | BLOOD PREPARATION USEFUL FOR WOUND HEALING AND TISSUE REGENERATION | Non-Final OA | NOVYSTEM S.P.A. |
| 17883618 | BEE-INGESTIBLE COMPOSITIONS, METHODS OF USING SAME FOR PRODUCING HONEY AND HONEY PRODUCED THEREBY | Final Rejection | Phytopharma International Ltd. |
| 17847975 | HIGH FIBER NUTRITIONAL COMPOSITIONS WITH IMPROVED ORGANOLEPTIC CHARACTERISTICS FOR BETTER DIET MANAGEMENT | Final Rejection | HAGE BT GLOBAL, LLC |
| 17773765 | COSMETIC USE OF AN AROMATIC RAW MATERIAL EXTRACT FOR PROTECTING SKIN FROM BLUE LIGHT | Non-Final OA | ROBERTET S.A. |
| 17433505 | MEDICAL ADHESIVE AND THE PREPARATION METHOD AND USE THEREOF | Final Rejection | Stomatological Hospital of ChongQing Medical University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy